ampicillin has been researched along with fosfomycin in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (29.09) | 18.7374 |
1990's | 7 (12.73) | 18.2507 |
2000's | 10 (18.18) | 29.6817 |
2010's | 17 (30.91) | 24.3611 |
2020's | 5 (9.09) | 2.80 |
Authors | Studies |
---|---|
Agouridas, C; Girodeau, JM; Le Goffic, F; Masson, M; Pineau, R | 1 |
Hoshiko, S; Ida, T; Maebashi, K; Miyata, A; Sanbongi, Y; Senju, N; Takahata, S | 1 |
Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fuller, CA; McGannon, CM; Weiss, AA | 1 |
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
Allison, SE; Barker, CA; Brown, ED; Capretta, AA; Das, R; Melacini, G; Nguyen, ND; Zlitni, S | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Blanco, C; Demay, F; Dhalluin, A; Ermel, G; Georgeault, S; Giard, JC; Gillet, R; Gomes Von Borowski, R; Hanh Le, H; Jean, M; Radigue, R; Thepaut, M; Trautwetter, A; Tresse, C; van de Weghe, P | 1 |
Abdel-Halim, M; Arthanari, H; Bader, CD; Chatterjee, D; Dahlem, C; Ducho, C; Engel, M; Fathalla, RK; Fischer, PD; Fröhner, W; Kiemer, AK; Mathea, S; Müller, R | 1 |
Fadon, A; Rodríguez, A; Sicilia, T; Soto, J | 1 |
Chico Rizzo, E | 1 |
Kong, YL; Miller, AK; Stapley, EO | 1 |
Daza, RM; Mendaza, MP; Perea, EJ | 1 |
Borowski, J; Linda, H | 2 |
Germiniani, R; Longoni, F; Maltempi, P; Orio, A | 1 |
Borobio, MV; Perea, EJ; Torres, MA | 1 |
Curtiss, R; Falkinham, JO | 1 |
Baquero, G; Figueroa, J; Otal, C; Rodríguez, A | 1 |
Andersen, JC; Juul-Jensen, KE; Nøhr, M | 1 |
Haidl, S; Hoffstedt, B; Ode, B; Ursing, J; Walder, M | 1 |
Bertrand, KP; Moyed, HS | 1 |
Stille, W | 1 |
Biolchi, S; Germiniani, R; Limido, P; Maltempi, P; Tajana, A | 1 |
Guggenbichler, JP | 1 |
Hosokawa, K; Kamitani, N; Kotsuji, F; Takeuchi, Y; Tominaga, T | 1 |
Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Suzuki, Y | 1 |
Kubo, S; Moriguchi, N; Yagi, K; Yamamoto, T; Yoshioka, K | 1 |
O'Connor, KA; Zusman, DR | 1 |
Harada, H; Kita, E; Kurioka, T; Yunou, Y | 1 |
Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
Katayama, N; Kuroiwa, H; Ono, K; Sakai, A; Sugiyama, M; Takano, H; Takio, S; Tanaka, K | 1 |
Tabata, M; Takata, T; Tsuruoka, T; Watabe, H | 1 |
Nagatomo, H; Sueyoshi, M; Taura, Y; Uemura, R | 1 |
Eiros Bouza, JM; Ochoa Sangrador, C | 1 |
Blázquez, J; López, E | 1 |
Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S | 1 |
Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H | 1 |
Clec'h, C; Cohen, Y; Jauréguy, F; Mellon, G; Picard, B | 1 |
Doki, Y; Ikeguchi, N; Mori, M; Nakajima, K; Nishida, T; Nishimura, J; Shinohara, N; Souma, Y; Takahashi, T; Takenaka, R | 1 |
Bétrisey, B; Furustrand Tafin, U; Jeddari, S; Maiolo, EM; Oliva, A; Trampuz, A | 1 |
Dörries, K; Lalk, M; Schlueter, R | 1 |
Chaudhary, U; Mittal, S; Sharma, M | 1 |
Chen, A; Eliopoulos, GM; Hirsch, EB; Kirby, JE; McCoy, C; Raux, BR; Zucchi, PC | 1 |
Maltas, J; Wood, KB | 1 |
Bekele, A; Gandhi, A; Garimella, N; Hartman, N; Li, X; Sacks, L; Stone, H; Weaver, JL; Zere, T | 1 |
Botelho, J; Hubbard, ATM; Hutton, W; Murphy, EA; Newire, E; Reiné, J; Roberts, AP; Wright, E | 1 |
Dobashi, M; Ikeda, M; Ishii, J; Koguchi, D; Murakami, Y | 1 |
Borges-Mateus, LM; Carmona-Cartaya, Y; González-Molina, MK; Hidalgo-Benito, M; Pereda-Novales, N; Quiñones-Pérez, D | 1 |
2 review(s) available for ampicillin and fosfomycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Etiological profile of urinary tract infections and antimicrobial susceptibility of urinary pathogens].
Topics: Adult; Age Factors; Aminoglycosides; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteria; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Consensus Development Conferences as Topic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Evidence-Based Medicine; Fosfomycin; Hospitalization; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Risk Factors; Spain; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
3 trial(s) available for ampicillin and fosfomycin
Article | Year |
---|---|
Prophylactic single-dose fosfomycin and metronidazole compared with neomycin, bacitracin, metronidazole and ampicillin in elective colorectal operations.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Bacitracin; Colorectal Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Neomycin; Premedication; Prospective Studies; Randomized Controlled Trials as Topic; Surgical Wound Infection | 1990 |
Fosfomycin versus ampicillin in the treatment of acute pyelonephritis.
Topics: Acute Disease; Ampicillin; Fosfomycin; Humans; Pyelonephritis; Random Allocation | 1988 |
[Short-term prevention of surgical infections with antibiotics. Preliminary results of a controlled clinical experimentation].
Topics: Ampicillin; Anti-Bacterial Agents; Clinical Trials as Topic; Fosfomycin; Humans; Kanamycin; Respiratory Tract Infections; Surgical Wound Infection; Urinary Tract Infections | 1982 |
50 other study(ies) available for ampicillin and fosfomycin
Article | Year |
---|---|
The lysine pathway as a target for a new genera of synthetic antibacterial antibiotics?
Topics: Amino Acid Isomerases; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Carboxy-Lyases; Diaminopimelic Acid; Lysine; Racemases and Epimerases; Structure-Activity Relationship | 1986 |
Horizontal gene transfer of ftsI, encoding penicillin-binding protein 3, in Haemophilus influenzae.
Topics: Amino Acid Sequence; Ampicillin Resistance; Base Sequence; Electrophoresis, Gel, Pulsed-Field; Gene Transfer, Horizontal; Haemophilus influenzae; Molecular Sequence Data; Penicillin-Binding Proteins; Recombination, Genetic | 2007 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Different classes of antibiotics differentially influence shiga toxin production.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteriophages; Ciprofloxacin; Escherichia coli; Escherichia coli O157; Shiga Toxin; Sulfamethoxazole; Trimethoprim | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Degradation of MAC13243 and studies of the interaction of resulting thiourea compounds with the lipoprotein targeting chaperone LolA.
Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Proteins; Lipoproteins; Molecular Chaperones; Periplasmic Binding Proteins; Structure-Activity Relationship; Thiourea | 2013 |
Synthesis and evaluation of 1,3,4-oxadiazole derivatives for development as broad-spectrum antibiotics.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cell Survival; Drug Design; Drug Synergism; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxadiazoles | 2019 |
Identification and Biochemical Characterization of Pyrrolidinediones as Novel Inhibitors of the Bacterial Enzyme MurA.
Topics: Alkyl and Aryl Transferases; Anti-Bacterial Agents; Bacteria; Enzyme Inhibitors; Fosfomycin; Humans; Peptidoglycan; Succinimides | 2022 |
Fosfomycin in pneumococcal meningitis.
Topics: Adult; Ampicillin; Cerebrospinal Fluid; Child; Drug Interactions; Drug Therapy, Combination; Female; Fosfomycin; Gentamicins; Humans; Infant; Male; Meningitis, Pneumococcal; Middle Aged; Penicillin Resistance; Streptococcus pneumoniae | 1977 |
Antibiotic treatment of respiratory sepsis.
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Chloramphenicol; Cloxacillin; Fosfomycin; Gentamicins; Haemophilus Infections; Humans; Methicillin; Penicillin G; Polymyxins; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Staphylococcal Infections; Streptococcal Infections | 1976 |
Fosfomycin treatment of Haemophilus influenzae infection in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cephaloridine; Cephalothin; Chloramphenicol; Fosfomycin; Haemophilus Infections; Haemophilus influenzae; Injections, Subcutaneous; Mice; Penicillins; Tetracycline | 1977 |
Genetic localization of the resistance to fosfomycin.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Conjugation, Genetic; Enterobacteriaceae; Escherichia coli; Fosfomycin; Klebsiella; Penicillin Resistance; Recombination, Genetic; Streptomycin; Transduction, Genetic | 1977 |
Combined action of fosfomycin with beta-lactam and aminoglycoside antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Escherichia coli; Fosfomycin; Penicillin G; Penicillin Resistance; Staphylococcus aureus; Streptomycin | 1977 |
[Short term antibiotic prophylaxis of surgical infections using fosfomycin].
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Cephaloridine; Female; Fever; Fosfomycin; Humans; Injections, Intramuscular; Male; Middle Aged; Surgical Wound Infection; Time Factors | 1979 |
Synergism of fosfomycin-ampicillin and fosfomycin-chloramphenicol against Salmonella and Shigella.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Drug Synergism; Fosfomycin; Microbial Sensitivity Tests; Salmonella; Shigella | 1978 |
Studies on the combined action of phosphonomycin with streptomycin, penicillin G and ampicillin.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Synergism; Escherichia coli; Fosfomycin; Penicillin G; Penicillin Resistance; Staphylococcus aureus; Streptomycin | 1976 |
Isolation and characterization of conjugation-deficient mutants of Escherichia coli K-12.
Topics: Alanine; Ampicillin; Carbohydrate Metabolism; Conjugation, Genetic; DNA, Bacterial; Escherichia coli; Fermentation; Fosfomycin; Glutamates; Mutation; Penicillin Resistance; Plasmids | 1976 |
Treatment of typhoid fever with fosfomycin alone and associated to chloramphenicol or ampicillin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Child; Chloramphenicol; Drug Combinations; Drug Evaluation; Drug Synergism; Female; Fosfomycin; Humans; Injections, Intramuscular; Male; Middle Aged; Time Factors; Typhoid Fever | 1977 |
hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis.
Topics: Ampicillin; Chromosome Mapping; Chromosomes, Bacterial; Conjugation, Genetic; Cycloserine; Diaminopimelic Acid; Escherichia coli; Fosfomycin; Genes, Bacterial; Mutation; Penicillin Resistance; Peptidoglycan; Spheroplasts | 1983 |
The prognostic value of the antibiogram.
Topics: Amniotic Fluid; Ampicillin; Animals; Anti-Bacterial Agents; Bile; Cefaclor; Cephalexin; Escherichia coli Infections; Fosfomycin; Gentamicins; Humans; In Vitro Techniques; Kanamycin; Klebsiella Infections; Microbial Sensitivity Tests; Urine | 1983 |
[Purulent meningitis in children. II. Treatment and prognosis].
Topics: Ampicillin; Child; Child, Preschool; Chloramphenicol; Cortisone; Electrolytes; Fluid Therapy; Fosfomycin; Humans; Infant; Meningitis; Meningitis, Haemophilus; Meningitis, Pneumococcal; Penicillin G; Prognosis; Shock, Septic | 1982 |
Management of an infected urachal cyst during pregnancy.
Topics: Adult; Ampicillin; Carbenicillin; Cesarean Section; Female; Fosfomycin; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Urachal Cyst | 1994 |
[The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].
Topics: Aerobiosis; Ampicillin; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter jejuni; Cefaclor; Cephalosporins; Chloramphenicol; Drug Resistance, Microbial; Enteritis; Escherichia coli O157; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Penicillins; Salmonella; Tetracycline; Vibrio parahaemolyticus | 1997 |
[The drug sensitivity of enterohemorragic Escherichia coli and antibiotics treatment for hemorrhagic enterocolitis--from an outbreak of enterocolitis in Sakai city].
Topics: Administration, Oral; Ampicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Child; Disease Outbreaks; Drug Resistance, Microbial; Enterocolitis; Escherichia coli Infections; Escherichia coli O157; Fosfomycin; Humans; Japan; Kanamycin; Penicillins | 1997 |
Induction of beta-lactamase influences the course of development in Myxococcus xanthus.
Topics: Ampicillin; Bacterial Proteins; beta-Lactamases; Caseins; Chemotaxis; Culture Media; Cycloserine; Enzyme Induction; Fosfomycin; Mutation; Myxococcus xanthus; Protein Hydrolysates; Signal Transduction; Spores, Bacterial; Vancomycin | 1999 |
Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Toxins; Brain Chemistry; Disease Models, Animal; Disease Progression; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Kanamycin; Mice; Mice, Inbred C57BL; Norfloxacin; Protein-Energy Malnutrition; Reference Values; Sensitivity and Specificity; Shiga Toxins; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
Effects of antibiotics that inhibit the bacterial peptidoglycan synthesis pathway on moss chloroplast division.
Topics: Ampicillin; Anti-Bacterial Agents; Bacitracin; Bryopsida; Chloroplasts; Cycloserine; Fosfomycin; Peptidoglycan; Vancomycin | 2003 |
[Activity of fosfomycin against Escherichia coli O157:H7--morphological changes and production of Shiga toxins].
Topics: Ampicillin; Anti-Bacterial Agents; Bacteriolysis; Cell Wall; Chloramphenicol; Dose-Response Relationship, Drug; Escherichia coli O157; Fosfomycin; Kanamycin; Norfloxacin; Shiga Toxins | 2003 |
Effect of antimicrobial agents on the production and release of shiga toxin by enterotoxaemic Escherichia coli isolates from pigs.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Wall; Colistin; Edema Disease of Swine; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Fosfomycin; Gentamicins; Quinolones; Shiga Toxin 2; Sus scrofa; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Chloramphenicol; Chromosomes, Bacterial; Ciprofloxacin; Colistin; Escherichia coli; Fosfomycin; Gentamicins; Imipenem; Microbial Sensitivity Tests; Recombination, Genetic; Rifampin; Tetracycline; Trimethoprim | 2009 |
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin | 2010 |
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult | 2011 |
Postsurgical meningitis due to multiresistant Acinetobacter baumannii successfully treated with high doses of ampicillin/sulbactam combined with rifampicin and fosfomycin.
Topics: Accidents, Traffic; Acinetobacter baumannii; Acinetobacter Infections; Adult; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fosfomycin; Humans; Male; Meningitis, Bacterial; Postoperative Complications; Rifampin; Sulbactam | 2012 |
The possibility of using fibrin-based collagen as an antibiotic delivery system.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aprotinin; Ciprofloxacin; Dibekacin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Delivery Systems; Escherichia coli; Fibrinogen; Fosfomycin; Gentamicins; Mice; Mice, Inbred C57BL; Polytetrafluoroethylene; Thrombin | 2013 |
Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calorimetry; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Foreign Bodies; Fosfomycin; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Vancomycin | 2014 |
Impact of antibiotics with various target sites on the metabolome of Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Erythromycin; Fosfomycin; Metabolic Networks and Pathways; Metabolome; Peptidoglycan; Staphylococcus aureus; Vancomycin | 2014 |
Fosfomycin use in multi drug resistant uropathogenic Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Netilmicin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Urine; Uropathogenic Escherichia coli; Virulence Factors | 2015 |
Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fosfomycin; Microbial Sensitivity Tests; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2016 |
Pervasive and diverse collateral sensitivity profiles inform optimal strategies to limit antibiotic resistance.
Topics: Ampicillin; Anti-Bacterial Agents; Directed Molecular Evolution; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterococcus faecalis; Fosfomycin; Genetic Fitness; Genome, Bacterial; Microbial Sensitivity Tests; Models, Statistical; Mutation; Rifampin; Selection, Genetic; Stochastic Processes; Tigecycline; Whole Genome Sequencing | 2019 |
Effect of drug combinations on the kinetics of antibiotic resistance emergence in Escherichia coli CFT073 using an in vitro hollow-fibre infection model.
Topics: Ampicillin; Anti-Bacterial Agents; Bioreactors; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fosfomycin; Humans; Microbial Sensitivity Tests | 2020 |
Isolation of an antimicrobial-resistant, biofilm-forming, Klebsiella grimontii isolate from a reusable water bottle.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Biofilms; Drinking Water; Drug Resistance, Multiple, Bacterial; Fosfomycin; Genome, Bacterial; Humans; Klebsiella; Microbial Sensitivity Tests; Polypropylenes; Polystyrenes; Virulence Factors; Water Microbiology; Whole Genome Sequencing | 2020 |
Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Cefaclor; Cefazolin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fosfomycin; Humans; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2020 |
Community-Acquired Uropathogenic
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Ciprofloxacin; Colistin; Cross-Sectional Studies; Cuba; Escherichia coli Proteins; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2022 |